Avacta Group Plc (AIM:AVCT)
31.00
+0.50 (1.64%)
Jun 27, 2025, 4:35 PM GMT+1
Revenue by Product
Fiscal year is January - December.
Year Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | NaN - NaN |
---|---|---|---|---|---|---|
Diagnostics | 21.19M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Diagnostics Growth | 407.96% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Therapeutics | 2.06M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Therapeutics Growth | -62.51% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Animal Health | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Animal Health Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Year Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | NaN - NaN |
---|---|---|---|---|---|---|
United Kingdom | 12.75M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United Kingdom Growth | 403.55% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
France | 4.12M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
France Growth | 217.90% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rest of Europe | 3.69M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rest of Europe Growth | 2234.18% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
South Korea | 2.06M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
South Korea Growth | -62.51% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rest of World | 613.00K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rest of World Growth | 8657.14% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
North America | 21.00K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
North America Growth | -88.27% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Asia | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Asia Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|